XERS

Xeris Biopharma Holdings, Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$6.04

Market Cap

$1.04B

Beta

0.97

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+43.72%

EPS Growth (YoY)+97.89%

Revenue CAGR 3Y+38.33%

P/E Ratio0.0

PEG Ratio—

FCF Yield+3.63%

Debt / Equity2.76

Interest Coverage0.9x

No credit card required

Already have an account? Sign in to view the full analysis for XERS.